Tinnitus Clinical Trial
Official title:
A Comparison of the Benefits of Mindfulness Based Cognitive Therapy, Relaxation Therapy and a Waiting List Control in the Management of Distress in Chronic Tinnitus Patients.
The principal hypotheses to be tested is that Mindfulness Based Cognitive Therapy (MBCT)
reduces the distressing impact of tinnitus to a significantly greater extent than a waiting
list control or relaxation therapy.
This study is a mixed design, with two groups assessed at a number of time points. The
primary outcome measure will be that of tinnitus distress, and secondary outcomes will be
taken of psychological distress and tinnitus loudness.
The outcome measures will be measured first at 8 weeks pre-treatment. All subjects then wait
for 8 weeks before being randomly allocated to either an 8 week course of Mindfulness-Based
Cognitive Therapy (MBCT) (Group 1) or an 8 week course of Relaxation Therapy (RT) (Group 2).
All participants will be assessed at two main time-points (pre and post-treatment). The
outcome measures will be repeated at 1 and 6 month follow-up points.
Experimental design and methods (including statistical analysis)
Participant recruitment:
Potential participants who meet the eligibility criteria will be identified from among
patients referred to the adult clinical psychology service within the department of Adult
Audiology at the Royal National Throat Nose & Ear Hospital. These patients will be
approached and invited to discuss participation in the project. The potential participants
will be given full information about the study and invited to consider whether they wish to
participate.
Design
This study an independent groups, repeated measures design. Two groups will be assessed at
different time points. Group 1 will receive 8 weeks of Mindfulness-Based Cognitive Therapy
(MBCT) and Group 2 will receive 8 weeks of Relaxation Training (RT; an active control). All
participants will be assessed at five main time-points:
- 8 weeks pre-treatment,
- The start of treatment
- The end of treatment
- 1 month follow-up
- 6 month follow-up
The primary outcome measure will be that of tinnitus complaint, and secondary outcome
measures will be taken of psychological distress and tinnitus loudness, tinnitus acceptance
and everyday mindfulness.
Measures:
A number of Questionnaire measures and a Visual Analogue Scale will be used to assess
tinnitus complaint, psychological well-being and mindfulness.
Participants are evaluated on all measures at initial assessment (8 weeks pre-treatment), at
treatment commencement, at end of treatment and at 1and 6 month follow-up.
Statistical Analyses
The primary outcome will be the change in tinnitus complaint as measured by the Tinnitus
Questionnaire from pre-treatment to post-treatment. This will be assessed by using t-tests.
Further statistical exploration will use t-tests to assess change from initial assessment to
end of the 8-week waiting period, and to assess change or maintenance of change from the end
of treatment to the 1and 6 month follow-up points. The same type of analysis will be done on
the measures of psychological well-being.
To assess for differences in outcome between the MBCT and RT groups, a series of
repeated-measures (2x2) (Group 1 - Group 2 x pre-treatment - post-treatment) ANOVAS will be
carried out. This will allow for the assessment of between group effects and any interaction
effects between group and time.
A number of correlations will also be performed to assess for relationships between
psychological distress pre-treatment and tinnitus outcome within each group. Correlation
will also be performed to assess for relationships between changes in tinnitus complaint and
tinnitus acceptance and everyday mindfulness. They will also be performed to assess for
relationships between changes in psychological distress and everyday mindfulness.
Chi-square analyses will be carried out on the measures of tinnitus complaint and CORE-OM
score pre- and post-treatment to assess for the numbers of patients within each group who
demonstrate clinically significant change. A clinically significant change in tinnitus
complaint is defined as change of at least 10 points reduction on the TQ. A clinically
significant change in psychological well-being is defined as a reduction of at least 0.5 on
the total mean CORE-OM score.
Correlations will be performed to assess for possible associations between patient
characteristics, attendance, amount of home practice and various outcomes. Weekly measures
of mindfulness will be used to explore the temporal sequence of change.
Methodology:
All participants will be assessed using all of the measures described above over a 2 week
period. They will then be randomly assigned to one of two groups: Group 1 will be treated
using an 8 week course of Mindfulness-Based Cognitive Therapy (MBCT). Group 2 will be
treated using an 8 week course of Relaxation Training (RT).This randomization will be
carried out by a member of staff at the Ear Institute, who is independent from the clinical
part of the trial. He will use a computer programme to complete randomization.
After assessment, patients enter a 'waiting' stage of the trial, during which they receive
no intervention for eight weeks. Four weeks into the waiting time, all patients will be sent
a letter to confirm the dates and times at which their specific group will take place. On
the eighth week, participants will attend the first group session. At this point, prior to
commencement of the group, they will complete all of the measures described above for a
second time.
All participants will then attend 8 consecutive weeks of group treatment. Throughout this
treatment period, at the end of each session, participants will complete two brief measures
(the MAAS the TAQ). This is important as it will allow for the temporal sequence of change
to be assessed, offering an opportunity to explore the potential mediation effect of
mindfulness. At the end of the eighth week, they will again be asked to complete all of the
measures for a third time.
All participants will then be invited to attend two further sessions - at 1 and 6 months
after treatment completion. At the start of these sessions all participants will be asked to
complete all of the measures described above for a fourth and fifth time. These sessions
will also provide ongoing support to the participants as they will provide an opportunity to
discuss how they are after the groups have finished.
Thus MBCT will be compared to an active control condition (RT) and a passive control
condition (wait list control), and RT will also be compared to the passive wait-list control
condition.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Recruiting |
NCT04987502 -
Virtual Reality and Subjective Tinnitus
|
N/A | |
Recruiting |
NCT04404439 -
Treatment of Tinnitus With Migraine Medications
|
Phase 4 | |
Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
Completed |
NCT03552302 -
Effects of Yoga Exercise on Participates With Tinnitus
|
||
Enrolling by invitation |
NCT02617953 -
Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus
|
N/A | |
Completed |
NCT02269839 -
A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus
|
N/A | |
Withdrawn |
NCT01663467 -
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
|
N/A | |
Completed |
NCT02974543 -
Somatosensory Stimulation to Alleviate Tinnitus
|
N/A | |
Completed |
NCT01929837 -
Tinnitus rTMS 2013
|
N/A | |
Completed |
NCT01857661 -
The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial
|
N/A | |
Completed |
NCT01927991 -
Internet-based Self-help for Tinnitus: The Role of Support
|
N/A | |
Completed |
NCT01480193 -
New Therapy for Patients With Severe Tinnitus
|
N/A | |
Terminated |
NCT01412918 -
Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression
|
N/A | |
Completed |
NCT00748475 -
Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus
|
N/A | |
Completed |
NCT00371436 -
Progressive Intervention Program for Tinnitus Management
|
N/A | |
Completed |
NCT00733044 -
Cost-effectiveness of Multidisciplinary Management of Tinnitus
|
N/A | |
Active, not recruiting |
NCT05518682 -
Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus
|
N/A | |
Recruiting |
NCT05212298 -
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 |